Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
Disease Category: Endometriosis
Location: United States, OR
Do you have Mild to Moderate Endometriosis?
Phase 3, double-blind, placebo-controlled, randomized study evaluating the safety and efficacy of study med in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.
Up to 12 Office Visits
Patient Inclusion Criteria
- Age 18-49
- Subject is a premenopausal female, between 18 and 49 years of age, inclusive, at the time of signing consent
- Subject has a clinical diagnosis of endometriosis established by means of documented surgicalvisualization (laparoscopy or laparotomy) performed within 7 years of screening
Patient Exclusion Criteria
- Subject has a previous history of a severe, life-threatening or other significant sensitivity to any drug.
- Subject is less than 6 months postpartum, post-abortion, or post-pregnancy at the time of entry into the Screening Period.
Toni Myers, Site Manager
Clinical Trials of America, Inc
10 Coburg Road, Suite 200
Eugene, OR 97401
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these